| infocus-ecmdelange.nl | In Focus (founded by Elizabeth de Lange) provides courses and consulting on Pharmacokinetics, Microdialysis, Blood-brain barrier characteristics & transport, CNS drug target site distribution, pharmacodynamics and translational modelling… | consulting pharmacokinetic, pharmacokinetic microdialysis, pharmacokinetic pharmacodynamics | consulting, modelling, barrier, characteristics, blood | 6 |
| pharmtox.nl | …detection) ATP-dependent into membrane vesicles. PharmTox can deliver high quality large uniform batches with guaranteed transport ratios. Purposes: drug interaction studies; inhibition studies; substrate studies; pharmacokinetic studies | study pharmacokinetic, pharmacokinetic study | inside, dependent, throughput, vesicle, membrane | 5 |
| nvkfb.nl | Radboud Summer School “Introduction to Pharmacokinetic and Pharmacodynamic Analysis” – 17 June – 11 July 2024 | introduction pharmacokinetic, pharmacokinetic pharmacodynamic | pharmacology, clinical, society, annual, congress | 3 |
| trials-zwn.nl | A Phase 1/2 Open-label Study to Investigate the Safety, Efficacy, and Pharmacokinetics of Administration of Su... | efficacy pharmacokinetic, pharmacokinetic administration, safety pharmacokinetic, pharmacokinetic selective, tolerability pharmacokinetic | phase, study, cancer, cell, trial | 3 |
| margavanamersfoort.nl | …liver function studies, or examination for lymph node enlargement. Key studies needed are carcinogenesis pharmacokinetics, developmental and reproductive toxicology, and immune response. Frisch notes that LeVier has a copy of a 9… | carcinogenic pharmacokinetic, pharmacokinetic immunologic, immunological pharmacokinetic, pharmacokinetic study, carcinogenesis pharmacokinetic | dow, corning, cite, exhibit, implant | 3 |
| symphonyconsortium.nl | • A paradigm-shift in dosing, realising more optimal treatment of patients with both current standard half-life and novel extended half-life factor concentrates by pharmacokinetic (PK)-guided dosing based on population PK models instead… | factor pharmacokinetic, pharmacokinetic dosing, population pharmacokinetic, pharmacokinetic pk | patient, treatment, disorder, symphony, bleed | 3 |
| muurformules.nl | description of the time course of the concentration of medicines in blood and other body fluids, a field called pharmacokinetics. This research is still the basis of much of the work of the Leiden Academic Centre for Drug Research ( LACDR ) | pharmacokinetic map, field pharmacokinetic, pharmacokinetic research | formula, equation, explanation, law, force | 3 |
| empirilogic.nl | I am a Ph.D. pharmacist with more than 30 years of experience in pharmaceutical and biotechnology product development. Some of the domains I have been working in are: formulation development, assay development, in vivo pharmacology and… | pharmacology pharmacokinetic, pharmacokinetic biotechnology | decision, risk, analysis, pharmaceutical, understand | 2 |
| abcofblood.nl | …services that can get you the answers you need. As your partner, we can discover the beneficial or adverse biological effects your compound(s) may trigger, define the optimal concentration to be used, and analyze its pharmacokinetics. | | blood, answer, immune, cell, analytical | 1 |
| t3-4-hypotrial.nl | In this run-in stage all patients switch to blinded generic LT4. This is because there are multiple LT4 preparations available with different pharmacokinetic properties, which would otherwise introduce substantial bias in the trial… | different pharmacokinetic, pharmacokinetic property | trial, criterion, patient, study, voor | 1 |
| chdr.nl | The Centre for Human Drug Research (CHDR) specialises in innovative early clinical drug research. We do this by asking the right questions at the right moment. | pharmacokinetic pharmacometrics | clinical, early, library, inflammation, metabolic | 0 |
| trc-p.nl | …primarily focussing on (bio)medical or students Biopharmaceutical Sciences. The TRC is a product of the Centre for Human Drug Research (CHDR), established in collaboration with primarily the Leiden University Medical Centre (LUMC). | pharmacokinetic elderly, pharmacokinetic interaction | treatment, receptor, inhibitor, cell, protein | 0 |